Get started
Author

Sujata Bhoi

Observed names: Bhoi Sujata, Bhoi, Sujata, S. Bhoi
Institution: Medivir (Sweden)
ORCID: 0009-0009-3953-9955
Observed ORCID: 0009-0009-3953-9955
OpenAlex ID: A5068271516
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
2015 · Larry Mansouri, Lesley-Ann Sutton, et al. · The Journal of Experimental Medicine · 113
PDF
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
2013 · Richard Rosenquist, Diego Cortese, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 79
PDF
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
2016 · Sujata Bhoi, Viktor Ljungström, et al. · Epigenetics · 31
PDF
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
2018 · Nikos Papakonstantinou, Stavroula Ntoufa, et al. · International Journal of Cancer · 28
PDF
Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression
2016 · Pradeep Kumar Kopparapu, Sujata Bhoi, et al. · Epigenetics · 23
PDF
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
2015 · S. Bhoi, P. Baliakas, et al. · Haematologica · 23
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
2019 · Maria Tsagiopoulou, Nikos Papakonstantinou, et al. · Clinical Epigenetics · 22
PDF
Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes
2014 · Sònia Tugues, Francis Roche, et al. · PLoS ONE · 21
PDF
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
2024 · Ruth Plummer, Alastair Greystoke, et al. · Journal of Hepatocellular Carcinoma · 4
PDF
A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110
2022 · Martí Duran-Ferrer, Larry Mansouri, et al. · Blood · 4
Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia
2014 · Larry Mansouri, Lesley-Ann Sutton, et al. · Blood · 2
986P Fostrox (fostroxacitabine bralpamide) plus lenvatinib in patients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC) progressed on immunotherapy combinations: Results from a multi-center phase Ib/IIa study
2024 · H. Chon, J. Heo, et al. · Annals of Oncology · 1
PDF
First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular carcinoma (HCC).
2024 · Maria Reig, T.R. Jeffry Evans, et al. · Journal of Clinical Oncology · 1
PDF
Supplementary Data1 from A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma
2026 · Hong Jae Chon, Jeong Heo, et al.
Data from A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma
2026 · Hong Jae Chon, Jeong Heo, et al.
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma
2026 · Hong Jae Chon, Jeong Heo, et al. · Clinical Cancer Research
176P Liver pharmacodynamics in an open-label phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in 2L/3L hepatocellular carcinoma
2024 · H.J. Chon, J. Heo, et al. · Annals of Oncology
PDF
Abstract 2691: A triple combination of fostrox (MIV-818) with immune checkpoint and kinase inhibition shows increased anti-tumor efficacy in vivo
2023 · Fredrik G. Oberg, Sujata Bhoi, et al. · Cancer Research
455 Fostrox (MIV-818) in combination with anti-PD-1 shows increased efficacy in nonclinical tumor models in vivo
2022 · Fredrik Oberg, Sujata Bhoi, et al. · Journal for ImmunoTherapy of Cancer
PDF
527P Phase I study of the novel prodrug MIV-818 in patients with hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA) or liver metastases (LM)
2021 · D. Sarker, T.R.J. Evans, et al. · Annals of Oncology
PDF
MOESM8 of DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
2019 · Tsagiopoulou, Maria, Papakonstantinou, Nikos, et al. · Figshare
MOESM6 of DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
2019 · Tsagiopoulou, Maria, Papakonstantinou, Nikos, et al. · Figshare
MOESM5 of DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
2019 · Tsagiopoulou, Maria, Papakonstantinou, Nikos, et al. · Figshare
MOESM1 of DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
2019 · Tsagiopoulou, Maria, Papakonstantinou, Nikos, et al. · Figshare
MOESM4 of DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
2019 · Tsagiopoulou, Maria, Papakonstantinou, Nikos, et al. · Figshare
Works count: 32
Citation count: 352
H-index: 8
I10-index: 8
Year
Topic
Type